Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
mHealth Market Forecast to 2028 - COVID-19 Impact and Analysis - by Service (Remote Monitoring, Diagnosis, Treatment, Health Support, Fitness & Wellness, and Other Services), Devices (Insulin Pump, BP Monitor, Glucose Monitor, Personal Pulse Oximeter, and Other Devices), and End User (Mobile Operators, Devices Vendors, Health Providers, and Others), and Geography
... and Other Devices), and End User (Mobile Operators, Devices Vendors, Health Providers, and Others), and Geography The mHealth market is projected to reach US$ 410.39 billion by 2028 from US$ 70.83 billion in 2021; it ... Read More
-
In-Vitro Diagnostics/IVD Market by Product and Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2026
... to reach USD 113.1 billion by 2026 from USD 98.2 billion in 2021, at a CAGR of 2.9% during the forecast period. The growth of the IVD market is mainly driven by the rising geriatric ... Read More
-
U.S. Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 The U.S. clinical ... Read More
-
Active Pharmaceutical Ingredient Market: Segmented By Type (Innovative and Generic); By Type of Synthesis (Synthetic and Biotech); By Application (Communicable Diseases, Oncology, Cardiovascular Diseases, Diabetes, Pain Management, Chronic Respiratory Diseases, and Other) and Region – Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030
... Global Analysis of Market Size, Share & Trends for 2019–2020 and Forecasts to 2030 Global Active Pharmaceutical Ingredient to surpass USD 336 billion by 2030 from USD 188 billion in 2020 at a CAGR 6.23% ... Read More
-
Diabetes Drug Market, Size, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis
... indicated by high blood sugar levels. It is caused by a malfunction in the pancreas, which secretes insulin. Besides, diabetes is also referred to as diabetes mellitus. High blood sugar levels cause thirst, hunger, and ... Read More
-
Type2 Diabetes Mellitus- Pipeline Insight, 2022
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Type2 ... Read More
-
Global Generic Injectables Market (2022 Edition) – Analysis By Molecule Type, (Small, Large), Therapeutic Area, Container Type, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2022-2027)
... injectables market was valued at USD 134 billion in the year 2021 with the North American region leading the regional market share. Some of the key factors driving the generic injectables market growth are the ... Read More
-
Global Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Regional Outlook and Forecast, 2021 - 2027
... Global Insulin Syringes Market size is expected to reach $2.1 billion by 2027, rising at a market growth of 4.5% CAGR during the forecast period. Insulin controls the body's fat and glucose metabolism. It is ... Read More
-
Diabetes Handbook & Resource Guide
... individuals, family members, and caregivers affected by diabetes. For those providing care and support to individuals with diabetes, this resource provides easy-to-understand and helpful information about diabetes and connects readers to many sources of support Read More
-
Diabetic Shoes Market
... the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision. Market Segmentation The global diabetic ... Read More
-
Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) pipeline Target constitutes close to 20 molecules. Out of which approximately 17 molecules are developed by companies and remaining by the universities/institutes. The ... Read More
-
North America Insulin Syringes Market Size, Share & Industry Trends Analysis Report By Disease (Type 2 Diabetes and Type 1 Diabetes), By Syringe Size, By End User, By Country and Growth Forecast, 2021 - 2027
... The North America Insulin Syringes Market would witness market growth of 3.0% CAGR during the forecast period (2021-2027). Diabetic people are more susceptible to COVID-19 infection and hence seek good glycemic management. As a result ... Read More
-
Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Diseases, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Other Applications] and Distribution Channel (Patients, Providers, Payers, and Employers)
... Providers, Payers, and Employers) The global digital therapeutics market is expected to grow from US$ 4,226.94 million in 2021 to US$ 18,061.79 million by 2028; it is estimated to grow at a CAGR of 23.1% ... Read More
-
Global Oral Clinical Nutrition Supplement Market Size study, by Product Type (Standard Formula, Specialised Formula) by Indication (General Well-being, Renal Disorders, Hepatic Disorders, Oncology Nutrition, Diabetes, Dysphagia, IBD & GI Tract Disorders, Neurological Disorders, Respiratory Orders, Others) by Form (Liquid, Semi-solid, Powder) by Flavor (Regular, Flavored) by Channel (Prescription-based, Over-the-Counter) by End User (foods & beverages, Pharmaceutical, Textiles, Petrochemicals, Adhesives, others) and Regional Forecasts 2022-2028
... Orders, Others) by Form (Liquid, Semi-solid, Powder) by Flavor (Regular, Flavored) by Channel (Prescription-based, Over-the-Counter) by End User (foods & beverages, Pharmaceutical, Textiles, Petrochemicals, Adhesives, others) and Regional Forecasts 2022-2028 Global Oral Clinical Nutrition Supplement ... Read More
-
2022 Global Forecast for Insulin Delivery Devices (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Prefilled Syringes Market by Material (Glass-based and Plastic-based), Design (Single-chamber Prefilled Syringes, Dual-chamber Prefilled Syringes, and Customized Prefilled Syringes), Therapeutic (Large Molecules and Small Molecules), and Application (Anaphylaxis, Rheumatoid Arthritis, Diabetes, and Others (Cancer, Multiple Sclerosis and Others)): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Sclerosis and Others)): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global prefilled syringes market was valued at $5,620.23 million in 2020, and is projected to reach $15,735.49 million by 2030, registering a CAGR of ... Read More
-
Global Diabetic Foot Ulcer Market, 2021-2027
... clinical presentation variable, and management requires early expert assessment. According to Gen Consulting Company, the global diabetic foot ulcer market is projected to reach USD 5,388 million, recording a CAGR of approximately 5.7 percent from ... Read More
-
2022 Global: Digital Diabetes Management - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
-
2022 Global: Diabetes Care Devices - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
-
2022 Global: Digital Therapeutic (Dtx) - Innovative Markets Forecast (2028) report
... 2017 through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression ... Read More
-
Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, CVD), By End User (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2022 - 2030
... to grow at a lucrative CAGR of 26.1% from 2022 to 2030. Key factors driving the market growth include high demand due to the COVID-19 pandemic, various supportive regulatory initiatives & early signs of reimbursements, ... Read More
-
Medication Adherence Global Market Report 2022 Including: 1) By Type: Hardware Centric; Software Centric 2) By Medication: Cardiovascular; Central Nervous System; Diabetes; Oncology; Respiratory; Gastrointestinal; Rheumatology; Others 3) By Application: Hospital; Retail Pharmacies; Long-Term Care Facilities; Mail-Order Pharmacies Covering: Koninklijke Philips N.V.; Cardinal Health Inc.; Omnicell Inc.; McKesson Corporation; Johnson & Johnson Services Inc.
... medication adherence market which is experiencing strong growth. The report gives a guide to the medication adherence market which will be shaping and changing our lives over the next ten years and beyond, including the ... Read More
-
Diabetic Footwear Market by Type (Shoes, Sandals, and Slippers), End User (Men and Women), and Distribution Channel(Online Platform, Specialty Stores, Footwear Stores, and Others): Global Opportunity Analysis and Industry Forecast, 2022–2031
... market size was valued at $5,802.5 million in 2020, and is projected to reach $14,183.7 million by 2031, registering a CAGR of 7.9% from 2022 to 2031. Diabetic footwear also known as extra depth shoes, ... Read More
-
Digital Health Global Market Report 2022 Including: 1) By Technology: Mobile Health (mhealth); Health Information Technology; Telehealth And Telemedicine; Health Analytics; Others 2) By Application: Cardiology; Diabetes; Neurology; Sleep Apnea; Oncology; Others 3) By End User: Healthcare Providers; Healthcare Payers; Pharmaceutical Companies; Others Covering: Allscripts Healthcare Solutions Inc.; BioTelemetry Inc.; eClinicalWorks; iHealth Lab Inc.; McKesson Corporation
... digital health market which is experiencing strong growth. The report gives a guide to the digital health market which will be shaping and changing our lives over the next ten years and beyond, including the ... Read More
-
Stem Cell/Cord Blood Banking Global Market Report 2022 Including: 1) By Cell Type: Adult Stem Cells; Umbilical Cord Blood Stem Cells; Embryonic Stem Cells 2) By Service: Collection; Processing; Analysis; Storage 3) By Bank Type: Public; Private 4) By Application: Leukemia; Anemia; Thalassemia; Autism; Cerebral Palsy; Diabetes; Others Covering: AMAG Pharmaceuticals; Cordlife; Cryo-Cell International; Esperite; Americord Registry LLC; China Cord Blood Corporation
... report focuses on the stem cell/cord blood banking market which is experiencing strong growth. The report gives a guide to the stem cell/cord blood banking market which will be shaping and changing our lives over ... Read More
Research Assistance
